Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thromboprophylaxis strategies for preventing blood clots after endovenous varicose vein treatment
ISRCTN18501431Phase 4Recruiting
- Sponsor
- Imperial College London
- Start
- Jan 2024
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, open-label trial of low molecular weight heparin calcium in venous thromboembolism (VTE) (3 arms), sponsored by Imperial College London. Primary endpoint: Composite venous thromboembolism. Started Jan 2024; status: recruiting.
02
Drugs
low molecular weight heparin calcium
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on ISRCTN18501431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18501431.